Bibliography

Export 797 results:

Author Title Type [ Year

]

2017

Clark US, Sweet LH, Morgello S, Philip NS, Cohen R. High early life stress and aberrant amygdala activity: risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging Behav. 2017 ;11(3):649-665.

Roth W, Morgello S, Goldman JE, Mohr JP, Elkind MSV, Marshall RS, Gutierrez J. Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging.; 2017 p. STROKEAHA.116.015630.

Roth W, Morgello S, Goldman JE, Mohr JP, Elkind MSV, Marshall RS, Gutierrez J. Histopathological Differences Between the Anterior and Posterior Brain Arteries as a Function of Aging. Stroke. 2017 ;48(3):638-644.

Nitkiewicz J, Borjabad A, Morgello S, Murray J, Chao W, Emdad L, Fisher P, Potash MJ, Volsky DJ. HIV induces expression of complement component C3 in astrocytes by NF-ΚB-dependent activation of interleukin-6 synthesis.; 2017.

Douville RN, Nath A. Human Endogenous Retrovirus-K and TDP-43 Expression Bridges ALS and HIV Neuropathology. [Internet]. 2017 ;8:1986. Available from: https://www.frontiersin.org/article/10.3389/fmicb.2017.01986

Mahajan SD, Aalinkeel R, Parikh NU, Jacob A, Cwiklinski K, Sandhu P, Le K, Loftus AW, Schwartz SA, Quigg RJ, et al. Immunomodulatory Role of Complement Proteins in the Neuropathology Associated with Opiate Abuse and HIV-1 Co-Morbidity. Immunological InvestigationsImmunological Investigations [Internet]. 2017 ;46(8):816 - 832. Available from: http://dx.doi.org/10.1080/08820139.2017.1371891

Kuhn T, Sayegh P, Jones JD, Smith J, Sarma MK, Ragin A, Singer EJ, M Thomas A, Thames AD, Castellon SA, et al. Improvements in brain and behavior following eradication of hepatitis C. J Neurovirol. 2017 ;23(4):593-602.

Yang J, Ngan DA, Tam S, Leung J, Sin DD, Man SP. Increased bacterial load in the small intestine but not lungs of HIV subjects. 2017 .

Christensen B, Qin Z, Byrd D, Yu F, Morgello S, Gelman B, Moore DJ, Grant I, Singer EJ, Fox HS, et al. Measures of Physical and Mental Independence Among HIV-Positive Individuals: Impact of Substance Use Disorder. AIDS Res Hum Retroviruses. 2017 ;33(10):1048-1055.

Xu Z, Asahchop EL, Branton WG, Gelman B, Power C, Hobman TC. MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology. PLoS Pathog. 2017 ;13(6):e1006360.

Wyczechowska D, Lin H-Y, LaPlante A, Jeansonne D, Lassak A, Parsons CH, Molina PE, Peruzzi F. A miRNA Signature for Cognitive Deficits and Alcohol Use Disorder in Persons Living with HIV/AIDS. [Internet]. 2017 ;10:385. Available from: https://www.frontiersin.org/article/10.3389/fnmol.2017.00385

Xing Y, Shepherd N, Lan J, Li W, Rane S, Gupta SK, Zhang S, Dong J, Yu Q. MMPs/TIMPs imbalances in the peripheral blood and cerebrospinal fluid are associated with the pathogenesis of HIV-1-associated neurocognitive disorders. Brain Behav Immun. 2017 .

Roda WC, Li MY, Akinwumi MS, Asahchop EL, Gelman B, Witwer KW, Power C. Modeling brain lentiviral infections during antiretroviral therapy in AIDS. J Neurovirol. 2017 ;23(4):577-586.

Shapshak P, Levine AJ, Foley BT, Somboonwit C, Singer EJ, Chiappelli F, Sinnott JT, Soontornniyomkij V. Neuropathology of HIV-1 disease. In: Global Virology II - HIV and NeuroAIDS. 1st ed. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 143-208.

Sanfilippo C, Pinzone MR, Cambria D, Longo A, Palumbo M, Di Marco R, Condorelli F, Nunnari G, Malaguarnera L, Di Rosa M. OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders. Mol Neurobiol. 2017 .

Singer EJ, Nemanim N. The Persistence of HIV-Associated Neurocognitive Disorder (HAND) in the Era of Combined Antiretroviral Therapy (cART). In: Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS. Springer; 2017. pp. 375-403.

Bryant AK, Moore DJ, Burdo TH, Lakritz JR, Gouaux B, Soontornniyomkij V, Achim C, Masliah E, Grant I, Levine AJ, et al. Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS. 2017 ;31(7):973-979.

Levine AJ, Martin EM, Sacktor N, Munro C, Becker JT. Predictors and Impact of Self-Reported Suboptimal Effort on Estimates of Prevalence of HIV-Associated Neurocognitive Disorders. JAIDS Journal of Acquired Immune Deficiency Syndromes [Internet]. 2017 ;75(2). Available from: http://journals.lww.com/jaids/Fulltext/2017/06010/Predictors_and_Impact_of_Self_Reported_Suboptimal.9.aspx

Mukerji SS, Misra V, Lorenz D, Cervantes-Arslanian AM, Lyons JL, Chalkias S, Wurcel A, Burke D, Venna N, Morgello S, et al. Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected Adults. J Acquir Immune Defic Syndr. 2017 ;75(2):246-255.

Robinson-Papp J, Navis A, Dhamoon MS, Clark US, Gutierrez-Contreras J, Morgello S. The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection. J Neuroimaging. 2017 .

2016

Saing T, Lagman M, Castrillon J, Gutierrez E, Guilford FT, Venketaraman V. Analysis of glutathione levels in the brain tissue samples from HIV-1-positive individuals and subject with Alzheimer's disease and its implication in the pathophysiology of the disease process. BBA Clinical. 2016 ;6:38-44.

Dever SM, Rodriguez M, El-Hage N. B-Adrenergic receptor gene expression in HIV-associate neurocognitive impairment and encephalitis: implications for MOR-1K subcellular localization. Journal of Neurovirology. 2016 .

Gutierrez J, Honig L, Elkind MSV, Mohr JP, Goldman JE, Dwork AJ, Morgello S, Marshall RS. Brain arterial aging and its relationship to Alzheimer Dementia. Neurology. 2016 ;86(16):1507-1515.

Gutierrez J, Menshawy K, Gonzalez M, Elkind MSV, Marshall RS, Dwork AJ, Morgello S. Brain large artery inflammation associated with human immunodeficiency virus and large artery remodeling. AIDS. 2016 ;30(3):415-423.

Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I. Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models. J Neuroimmune Pharmacol. 2016 ;11(3):495-510.

Pages